Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000227016 | SCV000285113 | pathogenic | Lynch syndrome | 2016-02-26 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 14-15 of the PMS2 gene. The 5' boundary is likely confined to intron 13. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated PMS2 protein. Truncating variants in PMS2 are known to be pathogenic. Gross deletions of exons 14-15 have been reported in an individual affected with endometrial cancer in the heterozygous state and in individuals with acute lymphoblastic leukemia and pleomorphic xanthoastrocytoma with cafe au lait spots (PMID: 21618646, 24440087). For these reasons, this variant has been classified as Pathogenic. |